Medicinal Product Shortages - update - 4 January 2023

Notice type: Advisory

Date: 04/01/2023

 

Further Information:

 The Health Products Regulatory Authority has been notified of a shortage of the following products:

  • Adizem-SR 90mg Prolonged Release Capsules - PA1688/001/001
  • Clarithromycin Teva 500mg Film-Coated Tablets - PA0749/148/002
  • Dalacin T Topical Lotion 10mg/ml Cutaneous Emulsion - PA0822/121/001
  • Keflex 250 mg/5ml Powder for Oral Suspension - PA1226/002/003
  • Oramox 125 mg/5ml Powder for Oral Suspension - PA0298/019/001
  • Oramox 250mg/5ml Powder for Oral Suspension - PA0298/019/002
  • Pinamox 250 mg/5ml Powder for Oral Suspension - PA0298/010/002
  • Valsartan 160mg Film Coated Tablets - PA2315/188/003

 

The following shortages have been resolved and supply has resumed to the Irish market:

  • Fucidin H 20mg/g + 10mg/g Cream - PA0046/005/005
  • Phenergan 25mg Film-Coated Tablets - PA23180/011/002

 

Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.




« Back